Search company, investor...


Founded Year



Series A | Alive

Total Raised


Last Raised

$20M | 1 yr ago

About Kintsugi

Kintsugi develops and offers smarter mental healthcare infrastructure using voice biomarkers to streamline access to care. It detects signs of clinical depression and anxiety using machine learning and voice biomarkers. The company was founded in 2019 and is based in Berkeley, California.

Headquarters Location

1569 Solano Avenue No. 365

Berkeley, California, 94707,

United States


Kintsugi's Product Videos

ESPs containing Kintsugi

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Biopharma Tech

The companies in this market develop measurable indicators of neurological function and mental health that can help guide treatment decisions and lead to improved patient outcomes. These vendors leverage a variety of data collection modalities, from wearables to digital devices.

Kintsugi named as Highflier among 14 other companies, including Neurotrack Technologies, Mindstrong, and Altoida.

Compete with Kintsugi?

Ensure that your company and products are accurately represented on our platform.

Kintsugi's Products & Differentiators

    Kintsugi Voice

    Kintsugi is AI technology that detects signs of depression and anxiety using vocal biomarkers. By analyzing only seconds of free form speech in any language, it can support clinicians with powerful mental health screening capabilities and help with early identification. Kintsugi Voice is an API product for payer organizations, healthcare institutions, telehealth platforms, call centers, remote patient monitoring, and more. With patient consent, Kintsugi Voice acts as an extra layer on clinical visits and flags whether the patient may need further mental health attention, in real time. Kintsugi Voice prevents patients’ conditions from worsening, and boosts business outcomes for payer and provider organizations, most significantly reducing costs and utilization. It is already used by a Fortune 5 payer and Fortune 20 systems.

Research containing Kintsugi

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Kintsugi in 1 CB Insights research brief, most recently on Dec 7, 2022.

Expert Collections containing Kintsugi

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kintsugi is included in 10 Expert Collections, including Mental Health Tech.


Mental Health Tech

1,410 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Wellness Tech

1,370 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.


Artificial Intelligence

10,393 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Beauty & Personal Care

858 items

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.


Health Monitoring & Diagnostics

2,623 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

12,523 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Kintsugi News

Kintsugi Thinking

Mar 21, 2023

Kintsugi Thinking Kintsugi thinking means reframing mistakes as learning opportunities. Mistakes are only failures when we don’t learn from them. By reframing our approach to mistakes, we can fail our way to success. The more we expose ourselves to making mistakes in the pursuit of progress, the more opportunity we give ourselves to learn. How we react to failure has an immense impact on others, from a parent’s reaction to a child’s mistake to the leader of one of the most successful organizations of all time. When we embrace mistakes as learning outcomes, we can uncover new capabilities, new innovations, and new opportunities. It is key to remember that there are always assets in the ashes. 0

Kintsugi Frequently Asked Questions (FAQ)

  • When was Kintsugi founded?

    Kintsugi was founded in 2019.

  • Where is Kintsugi's headquarters?

    Kintsugi's headquarters is located at 1569 Solano Avenue, Berkeley.

  • What is Kintsugi's latest funding round?

    Kintsugi's latest funding round is Series A.

  • How much did Kintsugi raise?

    Kintsugi raised a total of $28.38M.

  • Who are the investors of Kintsugi?

    Investors of Kintsugi include Darling Ventures, Acrew Capital, Insight Partners, AngelList, Side Door Ventures and 16 more.

  • Who are Kintsugi's competitors?

    Competitors of Kintsugi include aiberry, Winterlight Labs, Mindstrong, Deliberate AI, Canary Speech and 8 more.

  • What products does Kintsugi offer?

    Kintsugi's products include Kintsugi Voice and 1 more.

Compare Kintsugi to Competitors

Ellipsis Health Logo
Ellipsis Health

Ellipsis Health develops AI-generated vocal biomarker technology pioneering a new standard for identifying, assessing, and monitoring mental health. With a short voice sample, its technology determines the severity of anxiety and depression - creating an objective, personalized and scalable mental health tool. Ellipsis Health was founded in 2017 and is based in San Francisco, California.

Aural Analytics Logo
Aural Analytics

Aural Analytics uses speech to detect subtle but clinically meaningful changes in brain health. The platform is completely agnostic to disease, device, location and language and powers applications throughout the world. Aural Analytics was founded in 2015 and is based in Scottsdale, Arizona.

Sonde Health Logo
Sonde Health

Sonde Health is a health technology company that provides voice-enabled symptom detection and monitoring platform for chronic and mental health conditions. The platform analyzes vocal features that reflect changes in a user's voice caused by changing physiology of their body due to symptoms of the disease. The company was founded in 2015 and is based in Boston, Massachusetts.

Modality.AI Logo

Modality.AI detects health conditions using conversational AI. The company's platform analyzes the video of a user, recorded while the user interacts with an on-screen avatar, for facial movements and speech patterns to evaluate changes in neurological diseases to assess neurological and psychiatric states. Its platform can be used in clinics by physicians or as a point-of-care at home. It was founded in 2018 and is based in San Francisco, California.

Vocalis Health Logo
Vocalis Health

Vocalis Health is a vocal biomarker company using voice to detect, diagnose, and monitor patient health. Its technology leverages machine learning (ML) and deep learning (DL) techniques to analyze voice recordings for insights regarding various health conditions via a mobile application and web browser. The company was founded in 2019 and is based in Newton, Massachusetts.

Darmiyan Logo

Darmiyan develops fully automated proprietary software that inputs human brain MRIs and produces maps that detect Alzheimer's disease up to fifteen years before symptoms. Its mission is to create a fast, non-invasive, inexpensive, precise, and globally accessible tool for brain health screening and monitoring. Darmiyan's technology provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of microscopic abnormality in the brain.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.